Reappraisal of the Prostaglandin E1 Dose for Early Newborns with Patent Ductus Arteriosus-Dependent Pulmonary Circulation

• Main Authors: Fu-Kuei Huang (Author), Chu-Chuan Lin (Author), Ta-Cheng Huang (Author), Ken-Pen Weng (Author), Po-Yen Liu (Author), Ying-Yao Chen (Author), Hsiao-Ping Wang (Author), Luo-Ping Ger (Author), Kai-Sheng Hsieh (Author)
• Format: Book
• Published: Elsevier, 2013-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The usual initial dose of prostaglandin E1 (PGE1) for ductal-dependent congenital heart disease (CHD) is 50-100 ng/kg/minute. The aim of this study was to review our experience of a low initial dose of PGE1 treatment in early newborns with congenital heart disease and patent ductus arteriosus (PDA)-...